Intuitive Surgical, Inc. (NASDAQ:ISRG – Get Free Report) SVP Mark Brosius sold 464 shares of the firm’s stock in a transaction on Monday, December 15th. The shares were sold at an average price of $548.49, for a total transaction of $254,499.36. Following the sale, the senior vice president owned 443 shares in the company, valued at approximately $242,981.07. This trade represents a 51.16% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link.
Mark Brosius also recently made the following trade(s):
- On Friday, December 12th, Mark Brosius sold 4,500 shares of Intuitive Surgical stock. The shares were sold at an average price of $547.36, for a total transaction of $2,463,120.00.
Intuitive Surgical Stock Performance
Shares of Intuitive Surgical stock traded up $17.20 during trading hours on Monday, hitting $559.52. The company’s stock had a trading volume of 2,926,776 shares, compared to its average volume of 2,087,640. The company has a market cap of $200.58 billion, a PE ratio of 74.01, a PEG ratio of 4.98 and a beta of 1.68. The business has a 50 day moving average price of $529.62 and a two-hundred day moving average price of $505.36. Intuitive Surgical, Inc. has a 12-month low of $425.00 and a 12-month high of $616.00.
Wall Street Analyst Weigh In
A number of research firms have recently issued reports on ISRG. Sanford C. Bernstein reissued an “outperform” rating and issued a $685.00 target price on shares of Intuitive Surgical in a report on Tuesday, October 21st. Wells Fargo & Company lifted their price objective on shares of Intuitive Surgical from $600.00 to $654.00 and gave the stock an “overweight” rating in a research note on Friday. Hsbc Global Res raised Intuitive Surgical to a “strong-buy” rating in a research report on Thursday, October 23rd. Rothschild & Co Redburn raised their target price on Intuitive Surgical from $610.00 to $615.00 and gave the company a “buy” rating in a report on Thursday, October 23rd. Finally, Piper Sandler raised their price target on shares of Intuitive Surgical from $595.00 to $610.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 22nd. Two investment analysts have rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $608.79.
Read Our Latest Stock Analysis on ISRG
Hedge Funds Weigh In On Intuitive Surgical
Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Aaron Wealth Advisors LLC raised its position in shares of Intuitive Surgical by 0.8% in the 2nd quarter. Aaron Wealth Advisors LLC now owns 2,528 shares of the medical equipment provider’s stock worth $1,374,000 after acquiring an additional 19 shares in the last quarter. Prosperity Consulting Group LLC grew its stake in shares of Intuitive Surgical by 0.5% during the 3rd quarter. Prosperity Consulting Group LLC now owns 4,033 shares of the medical equipment provider’s stock worth $1,804,000 after purchasing an additional 19 shares during the period. Evergreen Capital Management LLC raised its holdings in Intuitive Surgical by 0.5% in the 1st quarter. Evergreen Capital Management LLC now owns 4,288 shares of the medical equipment provider’s stock valued at $2,124,000 after acquiring an additional 20 shares during the last quarter. Rise Advisors LLC increased its stake in Intuitive Surgical by 5.6% during the first quarter. Rise Advisors LLC now owns 378 shares of the medical equipment provider’s stock worth $187,000 after purchasing an additional 20 shares during the period. Finally, Rossmore Private Capital grew its holdings in shares of Intuitive Surgical by 2.0% during the third quarter. Rossmore Private Capital now owns 998 shares of the medical equipment provider’s stock worth $446,000 after purchasing an additional 20 shares during the last quarter. 83.64% of the stock is currently owned by hedge funds and other institutional investors.
About Intuitive Surgical
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
See Also
- Five stocks we like better than Intuitive Surgical
- Stock Average Calculator
- ServiceNow’s $7 Billion Gamble: Panic or Opportunity?
- How to Read Stock Charts for Beginners
- Dell and HP Are Raising Prices—And Investors Should Take Note
- Following Congress Stock Trades
- Why DLocal Is the Top Emerging Market Fintech Stock to Watch for 2026
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.
